Table 3.
Serum levels (pg/mL) of the molecules investigated.
| Primary Varicose Veins | Recurrent Varicose Veins | ||||||
|---|---|---|---|---|---|---|---|
| Molecules * | Mean | SD | SEM | Mean | SD | SEM | p-Value |
| sEng | 1450 | 624.0 | 87.38 | 1476 | 629.7 | 162.6 | 0.8857 |
| VEGFA | 88.66 | 54.78 | 7.826 | 89.41 | 52.57 | 13.57 | 0.9630 |
| sFLT1 | 152.6 | 45.53 | 6.314 | 125.8 | 34.75 | 8.973 | 0.0392 |
| sFLK | 10419 | 3806 | 527.7 | 10018 | 3544 | 915.0 | 0.7166 |
* Molecules investigated: sEng, soluble endoglin; VEGFA, vascular endothelial growth factor A; sFLT1, soluble fms-like tyrosine kinase 1 (sVEGFR1); sFLK, soluble foetal liver kinase (sVEGFR2).